Tricyclic compounds
AssigneeAbbott Laboratories
InventorsNeil Wishart, Kristine E. Frank, Michael Friedman, Dawn M. George, Kent D. Stewart, Grier A. Wallace
Life of this patent
Estimating the term…
Abstract
The invention provides compounds of Formula (I) and Formula (II) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Claims12
A compound selected from
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound represented by the following structure:
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound represented by the following structure:
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound represented by the following structure:
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound represented by the following structure:
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound selected from
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound represented by the following structure:
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound represented by the following structure:
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound represented by the following structure:
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound selected from
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound represented by the following structure:
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
A compound represented by the following structure:
- or pharmaceutically acceptable salts, stereoisomers and isomers thereof.
Dependencies are inferred from the claim text.